Better Obesity Drug Race: Novo Nordisk vs Lilly 2026
In the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
Understand when rebalancing triggers capital gains taxes and how to plan for them. This intro highlights key rules and proactive strategies.
23,600 articlesIn the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
As July approaches, a seasoned investor lays out why Apple sits at the center of their biggest July bet, citing the S...
July 1 brought a sharp move for CoreWeave as a Bloomberg note about Meta expanding into cloud services rattled AI inf...
MercadoLibre has faced a harsh year, sliding as investors fret about margins and investments. This guide explains why...
When spacex officially joined nasdaq-100, investors expected a jump in demand. Instead, the stock price moved lower a...
SK Hynix rode a Nasdaq debut to a turning point in AI hardware, with a $26.5 billion raise and 58% HBM market share. ...
Dell Technologies has surged on AI demand, pushing year-to-date gains toward 230% as investors bet the hardware giant...
As memory chip inventories weigh on the tech sector, the Dow shows remarkable resilience. This article breaks down wh...
Microsoft leans on three strategic ties—OpenAI, hardware collaboration with AMD, and Copilot enterprise adoption—to s...
Five infrastructure REITs are quietly powering AI workloads behind the scenes, but their stock returns haven’t kept p...
Goldman Sachs updated its governance policy to remove formal DEI criteria from director selection, aligning with peer...
As AI reshapes the job landscape in early 2026, workers face displacement and investors recalibrate. This report expl...